René‐Marc Flipo

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein et al. · New England Journal of Medicine · 2018 · 502 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

Jacques‐Eric Gottenberg, Philippe Ravaud, Thomas Bardin et al. · Arthritis & Rheumatism · 2010 · 303 citations

Life Sciences, Immunology, Pharmacotherapy +17

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 291 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

Pierre‐Antoine Juge, Raphaël Borie, Caroline Kannengiesser et al. · European Respiratory Journal · 2017 · 233 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Revisiting comorbidities in gout: a cluster analysis

Pascal Richette, Pierre Clerson, Laure Périssin et al. · Annals of the Rheumatic Diseases · 2013 · 180 citations · Full text

Medicine, Endocrinology, Clinical Epidemiology +16